LACOSAMIDE is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Breckenridge Pharmaceutical, Inc.. The primary component is Lacosamide.
| Product ID | 51991-348_21d8300b-b6d1-4a99-ac67-7fa92c1cc809 | 
| NDC | 51991-348 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | LACOSAMIDE | 
| Generic Name | Lacosamide | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2022-03-18 | 
| Marketing Category | ANDA / | 
| Application Number | ANDA204921 | 
| Labeler Name | Breckenridge Pharmaceutical, Inc. | 
| Substance Name | LACOSAMIDE | 
| Active Ingredient Strength | 50 mg/1 | 
| Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE] | 
| DEA Schedule | CV | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2022-03-18 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | ANDA | 
| Application Number | ANDA204921 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2016-06-15 | 
| Marketing End Date | 2016-06-16 | 
| Marketing Category | ANDA | 
| Application Number | ANDA204921 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2016-06-15 | 
| Marketing End Date | 2016-06-16 | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0121-0992 | Lacosamide | Lacosamide | 
| 0121-1984 | Lacosamide | Lacosamide | 
| 0121-2976 | Lacosamide | Lacosamide | 
| 0121-3968 | Lacosamide | Lacosamide | 
| 63850-0055 | Lacosamide | Lacosamide | 
| 63850-0053 | Lacosamide | Lacosamide | 
| 63850-0054 | Lacosamide | Lacosamide | 
| 63850-0056 | Lacosamide | Lacosamide | 
| 65162-912 | Lacosamide | Lacosamide | 
| 0131-1810 | Vimpat | lacosamide | 
| 0131-2470 | Vimpat | lacosamide | 
| 0131-2477 | Vimpat | lacosamide | 
| 0131-2478 | Vimpat | lacosamide | 
| 0131-2479 | Vimpat | lacosamide |